Article Details

Matinas BioPharma to Present New MAT2203 Data during IDWeek 2022 - MarketScreener

Retrieved on: 2022-10-13 18:01:27

Tags for this article:

Click the tags to see associated articles and topics

Matinas BioPharma to Present New MAT2203 Data during IDWeek 2022 - MarketScreener. View article details on hiswai:

Excerpt

BEDMINSTER - Matinas BioPharma Holdings, Inc. ( NYSE AMER : MTNB), a clinical-stage biopharmaceutical company focused on improving the ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up